EverSource Wealth Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$147K Sell
2,302
-826
-26% -$54.3K 0.01% 1181
2026
Q1
$223K Buy
3,128
+9
+0.3% +$710 0.01% 995
2025
Q4
$256K Buy
3,119
+221
+8% +$17.2K 0.01% 834
2025
Q3
$218K Buy
2,898
+405
+16% +$30.2K 0.01% 865
2025
Q2
$185K Sell
2,493
-131
-5% -$9.12K 0.01% 892
2025
Q1
$212K Buy
2,624
+530
+25% +$45.5K 0.01% 642
2024
Q4
$164K Buy
2,094
+484
+30% +$41.1K 0.01% 724
2024
Q3
$151K Buy
1,610
+20
+1% +$1.68K 0.01% 651
2024
Q2
$135K Buy
1,590
+127
+9% +$10.4K 0.01% 695
2024
Q1
$112K Buy
1,463
+961
+191% +$80K 0.01% 672
2023
Q4
$38.8K Buy
502
+3
+0.6% +$210 ﹤0.01% 994
2023
Q3
$33.9K Sell
499
-7
-1% -$509 ﹤0.01% 949
2023
Q2
$41.1K Sell
506
-41
-7% -$3.27K ﹤0.01% 915
2023
Q1
$44.9K Buy
+547
New +$39.1K 0.01% 825

Other funds holding GEHC

EverSource Wealth Advisors's GEHC Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its GE HealthCare (GEHC) stake by 26% in Q2 2026, selling an estimated $54.3K and leaving 2,302 shares worth $147K. The position accounts for 0.01% of the portfolio, ranked #1181.

EverSource Wealth Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $256K in Q4 2025. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • EverSource Wealth Advisors held 2,302 shares of GE HealthCare worth $147K as of Q2 2026.
  • EverSource Wealth Advisors sold 826 GE HealthCare shares in Q2 2026, an estimated $54.3K.
  • GE HealthCare made up 0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #1181 holding.
  • EverSource Wealth Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • EverSource Wealth Advisors's GE HealthCare position peaked at $256K in Q4 2025.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.